Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tapimmune Inc (TPIV)

Tapimmune Inc (TPIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tapimmune Inc 5 West Forsyth Street Suite 200 Jacksonville FL 32202 USA

P: 904-516-5436

Description:

TapImmune Inc. is an immunotherapy company. It specializes in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. The Company also develops therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection. It is involved in the development of HER2/neu for the treatment of breast cancer; and Folate Receptor Alpha, for the treatment of breast and ovarian cancer. TapImmune Inc. is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 114,341
Shares Outstanding, K 13,710
Annual Sales, $ 0 K
Annual Net Income, $ -10,980 K
Last Quarter Sales, $ 210 K
Last Quarter Net Income, $ -4,810 K
60-Month Beta -0.41
% of Insider Shareholders 3.30%
% of Institutional Shareholders 10.85%

Growth:

1-Year Return 163.92%
3-Year Return 26.36%
5-Year Return -56.56%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/21/18
Earnings Per Share ttm -1.35
EPS Growth vs. Prev Qtr -36.67%
EPS Growth vs. Prev Year -86.36%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-12 on 09/16/16

TPIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.01
Price/Earnings to Growth N/A
Return-on-Equity % -409.71%
Return-on-Assets % -247.73%
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 544.48
Price/Cash Flow N/A
Price/Book 21.52
Book Value/Share -0.39
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar